9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Eastern Cooperative Oncology Group
University of Southern California
UNC Lineberger Comprehensive Cancer Center
The University of Texas Health Science Center at San Antonio
Washington University School of Medicine
Tempus AI
Cedars-Sinai Medical Center
Pfizer
Taproot Health
National Cancer Institute (NCI)
Shanghai Changzheng Hospital
Peking University Third Hospital
Celgene
Merck Sharp & Dohme LLC
Peking University People's Hospital
Stanford University
Stanford University
University of South Florida